Chemokines, cytokines, and inflammatory cells in respiratory syncytial virus infection: Similarities to allergic responses

Pediatric Asthma, Allergy and Immunology

Volumn 14, Issue 2, 2000, Pages 93-100

  Welliver, Robert C ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHEMOKINE; CYTOKINE; EOTAXIN; FORMALDEHYDE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; RESPIRATORY SYNCYTIAL VIRUS VACCINE; TRANSCRIPTION FACTOR; VIRUS ANTIGEN;

ALLERGIC ASTHMA; BRONCHIOLITIS; BRONCHUS HYPERREACTIVITY; CELL STIMULATION; CHILD; COMPARATIVE STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; HUMAN; IMMUNE RESPONSE; INFANT; INFLAMMATORY CELL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; TH1 CELL; WHEEZING;

EID: 0033855124     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2000.14.93     Document Type: Review

References (43)

1. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD, Group Health Associates. Risk factors for respiratory syncytial virus-associated lower respiratory illness in the first year of life. Am J Epidemiol 1991; 133:1135-1151.
2. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM, Group Health Medical Associates. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112-1117.
3. Welliver RC, Kaul TN, Ogra PL. The appearance of cell-bound IgE in respiratory tract epithelium after respiratory syncytial virus infection. N Engl J Med 1980; 303:1198-1202.
4. Welliver RC, Kaul A, Ogra PL. Cell mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J Pediatr 1979; 94:370-375.
5. Cranage MP, Gardner PS. Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections. J Med Virol 1980; 5:161-170.
6. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay B. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407-1413.
7. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham S, Kay AB. Predominant TH2 like bronchoalveolar T-lymphocyte population in atopic asthma. N Eng J Med 1992; 326:5:298-304.
8. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338; 7:436-445.
9. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, DeVries JD, Romagnani S. IL-4 is an essential factor for the IgG synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988; 140:4193-4198.
10. Moser R, Fehr J, Bruijnzeel PL. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992; 149:1432-1438.
11. Venge J, Lampinen M, Hakansson L, Rak S, Venge P. Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allerg Clin Immunol 1996; 97:1110-1115.
12. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor -κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998; 177:1275-1281.
13. Chini BA, Fiedler MA, Milligan L, Hopkins T, Stark JM. Essential roles of NF-κB and C/EBP in the regulation of intercellular adhesion molecule-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures. J Virol 1998; 72:1623-1626.
14. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 265 (Lung Cell Mol Physiol) 1993; 9:L472-L478.
15. Einarsson O, Geba GP, Zhu Z, Landry M, Elias JA. Interleukin-11: Stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996; 97:915-924.
16. Thomas LH, Friedland JS, Sharland M, Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-κB nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of κBα. J Immunol 1998; 161:1007-1016.
17. Matsuzaki Z, Okamoto Y, Sarashina N, Ito E, Togawa K, Saito I. Induction of intercellular adhesion molecule-1 in human nasal epithelial cells during respiratory syncytial virus infection. Immunology 1996; 88:565-568.
18. Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra PL, Reyes VE. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-β and IL-1α. J Immunol 1996; 157:2506-2513.
19. Matsukura S, Kokubu F, Noda H, Tokunaga H, Adachi M. Expression of IL-6, IL-8, and RANGES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996; 98:1080-1087.
20. Johnston SL, Papi A, Bates PJ, Mastronarde JG, Monick MM, Hunninghake GW. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998; 160:6172-6181.
21. Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis 1995; 171:584-592.
22. Neuzil KM, Grajham BS. Cytokine release and innate immunity in respiratory syncytial virus infection. Sem Virol 1996; 7:255-264.
23. Saito T, Deskin RW, Casola A, Haeberle H, Olszewska B, Ernst PB, Alam R, Ogra PL, Garofalo R. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 1997; 175:497-504.
24. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo R. Cell-specific expression of RANTES, MCP-1 and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998; 72:4756-4764.
25. Noah TL, Wortman IA, Becker S. The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line. Immunopharmacology 1998; 39:193-199.
26. Becker S, Reed W, Henderson FW, Noah TL. RSV infection of human airway epithelial cells causes production of the βchemokine RANTES. Am J Physiol 1997; 272:L512-L520.
27. Sheeran P, Jafri H, Carubella C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999; 18:115-122.
28. Teran LM, Seminario MC, Shute JK, Papi A, Compton SJ, Low JL, Gleich GJ, Johnston SL. RANTES, Macrophage-inhibitory protein lα, and the eosinophil product major basic protein are released into upper respiratory secretions during virus-induced asthma exacerbations in children. J Infect Dis 1999; 179:677-681.
29. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytial virus-induced chemokine expression in the lower airways. Am J Respir Crit Care Med 1999; 159:1918-1924.
30. Welliver RC. Chemokines and cytokines in virus-induced wheezing. Collaborative Investigators' Symposium, American Academy of Allergy, Asthma and Immunology Annual Meeting, Orlando, FL, March 3, 1999.
31. Neilson KA, Yunis EJ. Demonstration of respiratory syncytial virus in an autopsy series. Pediatr Pathol 1990; 10:491-502.
32. Azzawi M, Bradley B, Jeffrey PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufri B, Collins JV, Durham S, Kay AB. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142:1407-1413.
33. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120:28-32.
34. Colocho Zelaya EA, Orvell C, Strannegard O. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr Allergy Immunol 1994; 5:100-106.
35. Garofalo R, Dorris A, Ahlstedt S, Welliver RC. Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease. Pediatr Allergy Immunol 1994; 5:111-117.
36. Reijonen TM, Korppi M, Kuikka L, Savolainen K, Kleemola M, Mononen I, Remes K. Serum eosinophil cationic protein as a predictor of wheezing after bronchiolitis. Pediatr Pulmonol 1997; 23:397-403.
37. Koller D, Wojnarowski C, Herkner KR, Weinlander G, Raderer M, Eichler I, Frischer T. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997; 99:752-756.
38. Martinez FD, Stern DA, Wright AL, Taussig LM, Halonen M. Differential immune responses to acute lower respiratory illness in early life and subsequent development of persistent wheezing and asthma. J Allergy Clin Immunol 1998; 102:915-920.
39. Ehlenfield DR, Cameroa K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000; 105:79-83.
40. + T cell clones. J Immunol 1988; 141:849-855.
41. Renzi PM, Turgeon JP, Yang JP, Drblik SP, Marcotte JE, Pedneault L, Spier S. Cellular immunity is activated and a Th-2 response is associated with early wheezing in infants after bronchiolitis. J Pediatr 1997; 130:584-593.
42. van Schaik SM, Tristram DA, Nagpal IS, Hintz KM, Welliver RC II, Welliver RC. Increased production of IFN-γ and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999; 103:630-636.
43. Oymar K, Elsayed S, Bjerknes R. Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol 1996; 7:180-186.